Companies: 10,795·Total market cap: $144.5T
Insmed Incorporated

Insmed Incorporated

INSMNASDAQHealthcare● Active
$94.22
$-10.70(-10.20%)
Market Cap$20.4B
P/E Ratio
52W High$212.75
52W Low$70.57
Overview

Insmed Incorporated (INSM) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

INSM · cash on hand · updated Dec 31, 2025

Core cash position

Cash & Short-Term Investments (CCE + ST Investments)
$1.43B -0.3% vs prior year
FY · as of Dec 31, 2025 · Reported in USD
Cash & Cash Equiv. (CCE)
$510.4M
cashAndCashEquivalents
Short-Term Investments
$919.6M
shortTermInvestments
YoY Change vs Prior Year
-0.3%
vs prior fiscal year
Latest Quarter
$1.22B
Q1 2026
Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash & ST Investments$1.43BCash on Hand
Total Debt$768.2MTotal Debt
Net Cash / Net Debt+$661.9MNet Cash Position
Cash vs Debt Ratio
Cash 65%Debt 35%

Insmed Incorporated has a net cash position of $661.9M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$1.43B$768.2M = +$661.9M

Cash on hand history

YoY Increase
YoY Decrease
Latest Year
INSM annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

DateCash & ST InvestmentsYoY Change
Dec 31, 2025Latest$1.43B-0.3%
Dec 31, 2024$1.43B+83.7%
Dec 31, 2023$780.4M-32.0%
Dec 31, 2022$1.15B+60.2%
Dec 31, 2021$716.8M+34.5%
INSM cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

#CompanyCash & ST Inv.Cash/MCap
#1
UnitedHealth Group Incorporated
UnitedHealth Group Incorporated
UNH
$28.12B7.8%
#2
Johnson & Johnson
Johnson & Johnson
JNJ
$20.10B3.6%
#3
Eli Lilly and Company
Eli Lilly and Company
LLY
$7.27B0.7%
#4
AbbVie Inc.
AbbVie Inc.
ABBV
$5.26B1.3%
#5
Insmed Incorporated
Insmed IncorporatedYOU
INSM
$1.43B7.0%
Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Insmed Incorporated (INSM) cash on hand as of December 31, 2025 is $1.43B, comprising $510.4M in cash and cash equivalents (CCE) plus $919.6M in short-term investments — reported as Insmed Incorporated cash and short-term investments on the balance sheet (10-K filing). Also referred to as Insmed Incorporated cash reserves or cash position.

Insmed Incorporated annual cash on hand history shows decreased -0.3% in 2025: decreased -0.3% in 2025. Insmed Incorporated cash reserves in 2025 reflect the company's capital allocation strategy.

Insmed Incorporated carries total debt of $768.2M against cash of $1.43B, resulting in a net cash position of +$661.9M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Frequently asked questions

INSM cash on hand · 5 questions

As of December 31, 2025, Insmed Incorporated (INSM) has $1.43B in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $510,445,000 in cash and cash equivalents (CCE) plus $919,602,000 in short-term investments. Latest quarter (March 31, 2026): $1.22B. Data sourced from the annual 10-K filing via FMP.

INSM cash on handINSM cash reservesINSM cash 2025how much cash does INSM have

Source: FMP /balance-sheet-statement · US GAAP · Insmed Incorporated · Insmed Incorporated SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025